Science
Type 2 diabetes risk detection
Type 2 diabetes risk detection
A recent large clinical study led by Lund University (Sweden) on multiple cohorts from Sweden, Finland, UK, Italy, Denmark, the Netherlands, USA and Germany have identified follistatin, a protein in the blood circulation, as a novel blood biomarker for the early prediction of Type 2 diabetes up to 19 years before diabetes onset.
Type 2 diabetes risk detection
Type 2 diabetes risk detection
Type 2 diabetes risk detection
Lundoch Diagnostics has developed an artificial intelligence (AI)-based computer program (LDT2D v. 210328) for individualized Type 2 diabetes prediction and risk assessment. By imputing patented blood biomarker measurements, the program predicts Type 2 diabetes 4 years or longer before diabetes onset.
Health solutions
Health solutions
Health solutions
Lundoch Diagnostics provides a health solution for Type 2 diabetes prevention, health management, nutrition and physical activity.
About us
Health solutions
Health solutions
Lundoch Diagnostics is a pioneering company in Type 2 diabetes prevention. Our mission is to provide a complete health solution base on precision preventative medicine.